drugset / Trial / NCT00905723

The Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women

NCT00905723

Phase 3 Unknown 60 enrolled Federal University of São Paulo
RandomizedParallel-groupDouble-blindTreatment

Summary

Climacterium is marked by hypoestrogenism and it is associated to drastic vasomotors symptoms, genital atrophy and humor alteration. Additionally, these symptoms impair sexual life and life quality. These effects can be counteracted by administration of estrogen therapy. However, estrogen therapy has side effects and isoflavone has been proposed as an estrogen substitute in reposition therapy. The aim of the randomized controlled trial is to evaluate the effects of isoflavone in the sex life assessed by a modified McCoy's sexual questionnaire.

Timeline

Start
2009-05
Primary completion
2010-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 1 mg
Subject Isoflavone Small molecule 150 mg

Indications

No indication recorded.